Advertisement
AnPac Bio-Medical Science... (ANPC)
NASDAQ: ANPC
· Real-Time Price · USD
4.30
-0.14 (-3.15%)
At close: May 19, 2023, 7:59 PM
Company Description
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China.
It also offers physical checkup package services.
The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
AnPac Bio-Medical Science Co. Ltd.
| Country | CN |
| IPO Date | Jan 30, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 89 |
| CEO | Dr. Chris Chang Yu |
Advertisement
Contact Details
Address: 801 Bixing Street Lishui, CN | |
| Website | https://www.anpacbio.com |
Stock Details
| Ticker Symbol | ANPC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001786511 |
| CUSIP Number | 03635R107 |
| ISIN Number | US03635R2067 |
| Employer ID | 00-0000000 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Dr. Chris Chang Yu | Co-Founder, Co-Chief Executive Officer & Co-Chairman |
| Dr. Sunil Pandit | U.S. Chief Executive Officer |
| Haohan Xu | Co-Chief Executive Officer & Co-Chairperson |
| Xiaoyu Li | Chief Financial Officer & Director |
| Dr. He Yu | Co-Founder & Chief Medical Officer |
| Weidong Dai | China Pres |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2025 | 6-K | Filing |
| Apr 02, 2025 | 6-K | Filing |
| Dec 23, 2024 | 6-K | Filing |
| Nov 14, 2024 | 6-K | Filing |
| Jul 24, 2024 | 6-K | Filing |
| Jun 26, 2024 | 8-K | Current Report |
| Jun 24, 2024 | F-6 POS | Filing |
| May 23, 2024 | 8-K | Current Report |
| Apr 22, 2024 | 8-K | Current Report |
| Apr 02, 2024 | 8-K | Current Report |